Brown Brothers Harriman & CO Charles River Laboratories International, Inc. Transaction History

Brown Brothers Harriman & CO

$14 Billion
Q3 2024

A detailed history of Brown Brothers Harriman & CO transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 134 shares of CRL stock, worth $26,233. This represents 0.0% of its overall portfolio holdings.

Number of Shares

134

Previous 125 7.2%

Holding current value

$26,233

Previous $25,000 4.0%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$187.96 - $245.29 $1,691 - $2,207	9 Added 7.2%	134 $26,000
Q2 2024 Aug 09, 2024	SELL	$206.39 - $268.73 $19,607 - $25,529	-95 Reduced 43.18%	125 $25,000
Q4 2023 Feb 12, 2024	BUY	$164.52 - $238.84 $15,629 - $22,689	95 Added 76.0%	220 $52,000
Q3 2023 Nov 13, 2023	SELL	$194.44 - $217.61 $81,470 - $91,178	-419 Reduced 77.02%	125 $24,000
Q2 2023 Aug 07, 2023	SELL	$183.71 - $210.25 $1.66 Million - $1.9 Million	-9,048 Reduced 94.33%	544 $114,000
Q1 2023 May 11, 2023	BUY	$191.89 - $259.92 $884,804 - $1.2 Million	4,611 Added 92.57%	9,592 $1.94 Million
Q4 2022 Feb 09, 2023	BUY	$197.11 - $250.07 $198,686 - $252,070	1,008 Added 25.37%	4,981 $1.08 Million
Q3 2022 Nov 10, 2022	BUY	$182.44 - $250.54 $105,085 - $144,311	576 Added 16.96%	3,973 $782,000
Q2 2022 Aug 11, 2022	BUY	$204.13 - $302.4 $59,810 - $88,603	293 Added 9.44%	3,397 $727,000
Q1 2022 May 13, 2022	BUY	$255.51 - $362.11 $117,534 - $166,570	460 Added 17.4%	3,104 $881,000
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $23,542 - $30,061	67 Added 2.6%	2,644 $996,000
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $67,820 - $83,410	182 Added 7.6%	2,577 $1.06 Million
Q2 2021 Aug 13, 2021	BUY	$294.17 - $371.65 $677,767 - $856,281	2,304 Added 2531.87%	2,395 $886,000
Q1 2021 May 13, 2021	SELL	$249.67 - $299.48 $1,747 - $2,096	-7 Reduced 7.14%	91 $26,000
Q4 2020 Feb 16, 2021	SELL	$222.0 - $252.62 $11,100 - $12,631	-50 Reduced 33.78%	98 $24,000
Q3 2020 Nov 16, 2020	BUY	$175.56 - $226.45 $4,915 - $6,340	28 Added 23.33%	148 $34,000
Q1 2020 May 15, 2020	BUY	$98.9 - $178.34 $1,186 - $2,140	12 Added 11.11%	120 $15,000
Q4 2019 Feb 14, 2020	SELL	$126.05 - $152.76 $189,075 - $229,140	-1,500 Reduced 93.28%	108 $16,000
Q1 2019 May 15, 2019	BUY	$104.82 - $146.73 $8,909 - $12,472	85 Added 5.58%	1,608 $234,000
Q4 2018 Feb 14, 2019	BUY	$105.09 - $137.23 $2,417 - $3,156	23 Added 1.53%	1,523 $172,000
Q3 2018 Nov 14, 2018	BUY	$112.11 - $134.54 $168,165 - $201,810	1,500 New	1,500 $202,000
Q1 2018 May 14, 2018	SELL	$98.19 - $115.2 $10,309 - $12,096	-105 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$100.43 - $118.09 $9,038 - $10,628	90 Added 600.0%	105 $11,000
Q2 2017 Aug 14, 2017	BUY	N/A	15	15 $2,000

Others Institutions Holding CRL

# of Institutions

696

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.96B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.

Account

Brown Brothers Harriman & CO Charles River Laboratories International, Inc. Transaction History